Welcome to the Laboratory Site of Shane Crotty, Ph.D

Back to Crotty Main Page on LIAI

crotty.jpgShane Crotty, Ph.D., and his team study immunity against infectious diseases. They investigate how the immune system remembers infections and vaccines. By remembering infections and vaccines, the body is protected from becoming infected in the future. Vaccines are one of the most cost-effective medical treatments in modern civilization and are responsible for saving millions of lives. Yet, good vaccines are very difficult to design, and a better understanding of immune memory will facilitate the ability to make new vaccines.

Most recently, Dr. Crotty’s immunity studies have led to the identification of an antibody that quickly fights the smallpox virus.  Dr. Crotty made the discovery while studying immunological memory to the smallpox vaccine, which is considered the “gold standard” of vaccines because it led to the eradication of this disease.  Despite this, the smallpox virus has been the subject of intense research interest worldwide in the last several years, prompted by bioterrorism concerns. The National Institutes of Health (NIH) has expressed interest in stockpiling Dr. Crotty’s antibody treatment nationwide alongside existing stockpiles of the smallpox vaccine. The NIH awarded Dr. Crotty a $7.1 million grant in the spring of 2008 to further those studies. Interest in Dr. Crotty’s research has been high because the younger portion of the U.S. population is not vaccinated against smallpox, and the antibody appears to successfully treat the disease.

Another important way in which Dr. Crotty's lab studies immune memory is by understanding the function of a gene called SH2D1A or SAP. This gene is mutated in the human genetic disease XLP (X-linked lymphoproliferative disease). Children affected by this disease are immunodeficient and usually die from infectious diseases before reaching adulthood. Dr. Crotty has discovered that the SAP gene plays a central role in generation of immune memory. Understanding the role of SAP in greater detail may help XLP patients and may, more broadly, allow for the design of better human vaccines that take advantage of SAP's important role in the process of generating immune memory.

News & Events:

National Institutes of Health Article:

Research Matters: Genetic Switch Discovered for Disease-Fighting Antibodies